• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    REGENXBIO Inc. - Common Stock (NQ:RGNX)

    15.03 -0.21 (-1.36%)
    Streaming Delayed Price Updated: 12:07 PM EST, Jan 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 163,713
    Open 15.02
    Bid (Size) 15.01 (100)
    Ask (Size) 15.05 (700)
    Prev. Close 15.24
    Today's Range 14.59 - 15.08
    52wk Range 5.035 - 15.80
    Shares Outstanding 43,466,186
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
    December 3, 2025 – Capricor Therapeutics (NASDAQ: CAPR) has sent shockwaves through the biotech sector today, witnessing an astonishing 535% surge in its stock price, propelling the company to an... 
    Via MarketMinute
    News headline image
    REGENXBIO (RGNX) Q3 2025 Earnings Call Transcript ↗
    REGENXBIO (RGNX) Q3 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings

    Performance

    YTD
    +10.8%
    +10.8%
    1 Month
    +13.5%
    +13.5%
    3 Month
    +23.0%
    +23.0%
    6 Month
    +63.9%
    +63.9%
    1 Year
    +79.8%
    +79.8%

    More News

    Read More
    News headline image
    REGENXBIO INC (NASDAQ:RGNX) Tops Q3 2025 Estimates, Shares Rise on Strong Results and Pipeline Progress ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
    Via Benzinga
    News headline image
    Analyst Expectations For Regenxbio's Future ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 7, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For May 12, 2025 ↗
    Via Benzinga
    News headline image
    What to Expect from Regenxbio's Earnings ↗
    Via Benzinga
    News headline image
    The Analyst Verdict: Regenxbio In The Eyes Of 7 Experts ↗
    Via Benzinga
    News headline image
    7 Analysts Assess Regenxbio: What You Need To Know ↗
    Via Benzinga
    News headline image
    A Glimpse Into The Expert Outlook On Regenxbio Through 6 Analysts ↗
    Via Benzinga
    News headline image
    Regenxbio Unveils 12-Month Data For Gene Therapy Soon After FDA Delays Review Date ↗
    Via Benzinga
    News headline image
    FDA Extends Decision Date On Regenxbio's Gene Therapy Into Next Year ↗
    Via Benzinga
    News headline image
    REGENXBIO INC (NASDAQ:RGNX) Reports Q2 2025 Earnings Miss, Stock Slides Amid Revenue and EPS Shortfalls ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Navigating the Currents: Top Sectors Primed for Growth in Q3 2025
    Via MarketMinute
    Topics Artificial Intelligence Economy Retirement
    News headline image
    A Glimpse Into The Expert Outlook On Regenxbio Through 8 Analysts ↗
    Via Benzinga
    News headline image
    Crude Oil Moves Higher; Ciena Posts Downbeat Earnings ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    News headline image
    Early Wins: RegenXBio's Gene Therapy Helps Duchenne Patients Walk Stronger, Longer ↗
    Via Benzinga
    News headline image
    Dow Dips Over 100 Points; US Jobless Claims Increase ↗
    Via Benzinga
    Topics Stocks
    News headline image
    Which stocks are gapping on Thursday? ↗
    Via Chartmill
    News headline image
    Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday ↗
    Via Benzinga
    News headline image
    The One-Minute Market Report - Saturday, April 26 ↗
    Via Talk Markets
    Topics ETFs Stocks / Equities
    News headline image
    Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost ↗
    Via Investor's Business Daily
    Topics Government
    News headline image
    What's going on in today's after hours session ↗
    Via Chartmill

    Frequently Asked Questions

    Is REGENXBIO Inc. - Common Stock publicly traded?
    Yes, REGENXBIO Inc. - Common Stock is publicly traded.
    What exchange does REGENXBIO Inc. - Common Stock trade on?
    REGENXBIO Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for REGENXBIO Inc. - Common Stock?
    The ticker symbol for REGENXBIO Inc. - Common Stock is RGNX on the Nasdaq Stock Market
    What is the current price of REGENXBIO Inc. - Common Stock?
    The current price of REGENXBIO Inc. - Common Stock is 15.03
    When was REGENXBIO Inc. - Common Stock last traded?
    The last trade of REGENXBIO Inc. - Common Stock was at 01/08/26 12:07 PM ET
    What is the market capitalization of REGENXBIO Inc. - Common Stock?
    The market capitalization of REGENXBIO Inc. - Common Stock is 653.41M
    How many shares of REGENXBIO Inc. - Common Stock are outstanding?
    REGENXBIO Inc. - Common Stock has 653M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.